RIPPLY1通过靶向TBX19抑制CTNNB1突变肝细胞癌的干细胞特性
本研究探讨RIPPLY1在CTNNB1突变肝细胞癌(HCC)中对癌细胞干性的调控机制。RIPPLY1受Wnt/β-catenin通路反式激活,在CTNNB1突变HCC组织中显著上调且与更好预后正相关;其缺失通过增强TBX19转录活性促进肿瘤发生和干细胞特性。
要点
- RIPPLY1在CTNNB1突变HCC中受Wnt/β-catenin通路激活而表达上调。
- RIPPLY1缺失通过增强TBX19转录活性促进癌细胞干性和肿瘤进展。
- RIPPLY1高表达与CTNNB1突变HCC患者更好预后正相关。
核心结论
- RIPPLY1缺失通过促进TBX19转录活性增强CTNNB1突变HCC的癌细胞干性。
研究设计与样本
- 研究采用人HCC样本分析、DEN/PB诱导和HDTVi诱导的CTNNB1突变HCC小鼠模型,以及细胞学实验。
主要发现
- RIPPLY1在CTNNB1突变HCC组织中显著上调,并与患者更好预后正相关。
- 肝细胞特异性敲除RIPPLY1促进DEN/PB诱导和HDTVi诱导的CTNNB1突变HCC小鼠模型中的肿瘤发生与进展。
- RIPPLY1敲除的肿瘤细胞干细胞标志物水平上调且癌症干细胞特性增强。
- RIPPLY1通过招募TLE1并促进TBX19蛋白酶体依赖性降解来抑制TBX19转录活性。
- TBX19缺失可消除RIPPLY1缺失对CTNNB1突变HCC癌细胞干性的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: CTNNB1 -mutated HCCs exhibit a relatively low stem-like and well-differentiated phenotype. However, the mechanism remains unclear. Ripply transcriptional repressor 1 (RIPPLY1), a transcriptional repressor required for somite segmentation, has hardly been studied in cancer. Here, we aim to unveil the role of RIPPLY1 in the regulation of cancer cell stemness in CTNNB1 -mutated HCCs. APPROACH AND RESULTS: RIPPLY1 was found to be transactivated by the Wnt/β-catenin signal pathway. Human sample analysis confirmed that RIPPLY1 was significantly upregulated in CTNNB1 -mutated HCC tissues and positively correlated with better prognosis of HCC patients. Hepatocyte-specific deletion of RIPPLY1 promoted tumorigenesis and progression in the DEN/PB-induced CTNNB1 -mutated HCC mouse model and the hydrodynamic tail-vein injection (HDTVi)-induced CTNNB1 -mutated HCC mouse model. RIPPLY1 knockout tumor cells displayed upregulated levels of stem cell makers and enhanced cancer stem cell properties. Co-immunoprecipitation and mass spectrometry identified TBX19 as the target protein of RIPPLY1. RIPPLY1 suppressed the transcriptional activity of TBX19 via recruiting TLE1 and promoting proteasome-dependent degradation of TBX19. TBX19 deficiency abolished the effect of RIPPLY1 loss on cancer cell stemness in CTNNB1 -mutated HCCs. CONCLUSIONS: Loss of RIPPLY1 promotes cancer cell stemness via facilitating the TBX19 transcriptional activity in CTNNB1 -mutated HCCs.
引用
- Zhangyuan G, Yu W, Tian W, et al. RIPPLY1 suppresses cancer cell stemness via targeting TBX19 in CTNNB1 -mutated hepatocellular carcinoma. Hepatology. 2025. PMID: 40901752. doi:10.1097/HEP.0000000000001483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。